Urogen Pharma Ltd. logo

Urogen Pharma Ltd. (URGN)

Market Closed
17 Jul, 20:00
NASDAQ (NMS) NASDAQ (NMS)
$
40. 23
+0.23
+0.575%
$
1.91B Market Cap
- P/E Ratio
- Div Yield
1.27M Volume
-3.56 Eps
$ 40
Previous Close
Add Transaction
Day Range
39.5 41.88
Year Range
14.33 41.88
Want to track URGN and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Name Time Cons. EPS Eps
Urogen Pharma Ltd. logo
URGN Urogen Pharma Ltd.
11 May 2026
-
-
Urogen Pharma Ltd. logo
URGN Urogen Pharma Ltd.
12 Mar 2026
-
-
Urogen Pharma Ltd. logo
URGN Urogen Pharma Ltd.
17 Nov 2025
-
-
Urogen Pharma Ltd. logo
URGN Urogen Pharma Ltd.
19 Aug 2025
-
-
Urogen Pharma Ltd. logo
URGN Urogen Pharma Ltd.
12 May 2025
-
-
Urogen Pharma Ltd. logo
URGN Urogen Pharma Ltd.
12 Mar 2025
-
-
Urogen Pharma Ltd. logo
URGN Urogen Pharma Ltd.
12 Nov 2024
-
-
Urogen Pharma Ltd. logo
URGN Urogen Pharma Ltd.
8 Aug 2024
-
-
Urogen Pharma Ltd. logo
URGN Urogen Pharma Ltd.
9 May 2024
-
-
Urogen Pharma Ltd. logo
URGN Urogen Pharma Ltd.
14 Mar 2024
-
-
Urogen Pharma Ltd. logo
URGN Urogen Pharma Ltd.
8 Nov 2023
-
-

URGN Earnings Reports FAQ

What is the earnings per share (EPS) for URGN?

The current EPS is -3.56.

What is the company's earnings growth rate?

Urogen Pharma Ltd has not announced its next earnings release date. You can monitor upcoming announcements in Marketlog's earnings calendar or in the company profile.

When is the next earnings release date?

Urogen Pharma Ltd has not announced its next earnings release date.

What were the most recent quarterly earnings?

The most recent quarterly earnings for Urogen Pharma Ltd are not available at this time.

What is the price-to-earnings (P/E) ratio?

There is no P/E ratio for URGN at this time, as Urogen Pharma Ltd has no recent EPS data to calculate it.